Nutritional AMD treatment phase I (NAT-1): Feasibility of oral DHA supplementation in age-related macular degeneration

European Journal of Ophthalmology

Volumn 19, Issue 1, 2009, Pages 100-106

  Querques, Giuseppe ^a,b   Benlian, P ^a   Chanu, B ^c   Portal, C ^a   Coscas, G ^a   Soubrane, G ^a   Souied, E H ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b UNIVERSITY OF FOGGIA   (Italy)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Age related macular degeneration; Apoptosis; Dietary supplementation; Docosahexaenoic acid; Omega 3; Polyunsaturated fatty acid

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ERYTHROCYTE MEMBRANE; EYE EXAMINATION; FATTY ACID BLOOD LEVEL; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION;

AGED; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; FEASIBILITY STUDIES; FEMALE; FISH OILS; HUMANS; MACULAR DEGENERATION; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 69249105050     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900115     Document Type: Article

References (40)

1. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003; 48: 257-93.
2. DeAngelis MM, Lane AM, Shah CP, Ott J, Dryja TP, Miller JW. Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 2004; 122: 575-80.
3. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996; 276: 1141-6.
4. Delcourt C, Diaz J, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration: the POLA Study. Arch Ophthalmol 1998; 116: 1031-5.
5. Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 2002; 120: 1357-63.
6. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992; 110: 1701-8.
7. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol 1998; 4: 535-47.
8. Mares-Perlman JA, Brady WE, Klein R, VanderLangenberg GM, Klein BEK, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995; 113: 743-8.
9. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998; 148: 204-14.
10. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005; 294: 3101-7.
11. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 2004; 122: 883-92.
12. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 2001; 119: 1417-36.
13. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272: 1413-20.
14. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004; 75: 216-30.
15. Delcourt C, Carriere I, Delage M, Barberger-Gateau P, Schalch W, POLA Study Group. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci 2006; 47: 2329-35.
16. Seddon JM, Rosner B, Sperduto RD, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 2001; 119: 1191-9.
17. Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol 2000; 118: 401-4.
18. Cho E, Willett WC, Spiegelman D, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001; 73: 209-18.
19. SanGiovanni JP, Chew EY, Clemons TE, et al. Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 2007; 125: 671-9.
20. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005; 24: 87-138.
21. Neuringer M, Anderson G, Connor WE. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu Rev Nutr 1988; 8: 517-54.
22. Souied E, Kaplan J, Coscas G, Soubrane G. DMLA et génétique. J Fr Ophtalmol 2001; 24: 875-85.
23. Connor KM, Sangiovanni JP, Lofqvist C, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007; 13: 868-73.
24. Koto T, Nagai N, Mochimaru H, et al. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 2007; 48: 4328-34.
25. Souied EH, Benlian P, Amouyel P, et al. The epsilon 4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998; 125: 353-9.
26. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 2006; 51: 316-63.
27. Simopoulos AP. n-3 fatty acids and human health: defining strategies for public policy. Lipids 2001; 36 (Suppl): S83-89.
28. Grundy S. N-3 fatty acids. Priority for post-myocardial infarction clinical trials. Circulation 2003; 107: 1834-6.
29. Das U. Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot Essent Fatty Acids 2000; 63: 351-62.
30. Rotstein NP, Politi LE, German OL, Girotti R. Protective effect of docosahexaenoic acid on oxidative stress-induced apoptosis of retina photoreceptors. Invest Ophthalmol Vis Sci 2003; 44: 2252-9.
31. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438-63.
32. Robinson WG, Kuwabara T, Bieiri JG. The roles of vitamin E and unsaturated fatty acids in the visual process. Retina 1982; 2: 263-81.
33. Bazan NG. The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res 1989; 312: 95-112.
34. Seddon JM, Ajani U, Sperduto R, et al. Dietary fat intake and age-related macular degeneration. Invest Ophthalmol Vis Sci 1994; 35: 2003.
35. Maruo T, Ikebukuro N, Kawanabe K, Kubota N. Changes in causes of visual handicaps in Tokyo. Jpn J Ophthalmol 1991; 35: 268-72.
36. Yuzawa M, Tamakoshi A, Kawamura T, Ohno Y, Uyama M, Honda T. Report on the nationwide epidemiological survey of exudative age-related macular degeneration in Japan. Int Ophthalmol 1997; 21: 1-3.
37. Lands WE, Hamazaki T, Yamazaki K, et al. Changing dietary patterns. Am J Clin Nutr 1990; 51: 991-3.
38. Ouchi M, Ikeda T, Nakamura K, Harino S, Kinoshita S. A novel relation of fatty acid with age-related macular degeneration. Ophthalmologica 2002; 216: 363-7.
39. Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K, Bird AC. The Prevalence of Age-Related Maculopathy in Iceland. Reykjavik Eye Study. Arch Ophthalmol 2003; 121: 379-85.
40. Hodge WG, Schachter HM, Barnes D, et al. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. Ophthalmology 2006; 113: 1165-72.